Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02333604 · ClinicalTrials.gov registry record
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
A clinical trial of Cancer and Neoplasms, sponsored by Cancer Support Community, Research and Training Institute, Philadelphia.
- Recruiting
- Registry status
- 15,000
- Enrollment target
- 1
- Study location
NCT02333604: Recruiting study of Cancer and Neoplasms, sponsored by Cancer Support Community, Research and Training Institute, Philadelphia.
NCT02333604 is a study of Cancer and Neoplasms that is actively recruiting participants, run by Cancer Support Community, Research and Training Institute, Philadelphia. The registered enrollment target is 15,000 participants, above the 3,467-participant average among 615 other Cancer trials with a reported enrollment target (333% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02333604, a study of Cancer and Neoplasms, is actively recruiting participants, sponsored by Cancer Support Community, Research and Training Institute, Philadelphia.
- RECRUITING
- Registry status
- 15,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Cancer Experience Registry®: An Online Survey Research Study to Understand the Experiences of Those Impacted By a Cancer Diagnosis. The Registry is a web-based platform to distribute cross-sectional and longitudinal surveys. Study surveys are designed based on input from advisor experts, including patients and caregivers, and focus on the social, emotional, physical, financial and decision-making experiences of those who have been diagnosed with cancer and their caregivers. Findings contribute toward enhancing care for patients, survivors and caregivers via programming and policy initiatives.
Primary Outcome
Participant self-reported symptoms and functioning will be measured using the Patient-Reported Outcomes Measurement Information System-Preference Score (PROMIS-Pr). Five domains assess symptoms with higher scores corresponding to worse symptomology (Depression; Anxiety; Pain Interference; Fatigue; Sleep Disturbance) and three assess function with lower scores corresponding to worse functioning (Physical Function; Ability to Participate in Social Roles and Activities; Cognitive Function). Partici
Study Locations (1)
District of Columbia
- Cancer Support Community Research & Training Institute - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2013-03 |
| Est. Completion | 2035-12 |
What NCT02333604 shows while recruiting
NCT02333604 is an observational study that tracks outcomes without assigning an intervention. Its 15,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,467-participant average among 615 other Cancer trials with a reported enrollment target (333% higher).
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT02333604 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT02333604 about?
NCT02333604 is a clinical study titled "Cancer Experience Registry (CER) for Cancer Patients and Caregivers". The Cancer Experience Registry®: An Online Survey Research Study to Understand the Experiences of Those Impacted By a Cancer Diagnosis. The Registry is a web-based platform to distribute cross-sectional and longitudinal surveys. Study surveys are designed based on input from advisor experts, includi...
What is the current status of trial NCT02333604?
This trial is currently recruiting. The enrollment target is 15,000 participants. The study started on 2013-03. Estimated completion is 2035-12.
What conditions does trial NCT02333604 study?
This clinical trial studies the following conditions: Cancer, Neoplasms, Caregiver.
Who is sponsoring clinical trial NCT02333604?
This trial is sponsored by Cancer Support Community, Research and Training Institute, Philadelphia, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02333604 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02333604's enrollment target sits among peer trials
15,000 20th of 615 higher than 595 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
- NCT03050762 · 15,000 participants
Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia